Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
45.13 USD | +1.69% | -1.47% | -25.13% |
11:30am | Legend Expects to Log Profit in 2026 | MT |
05-14 | HC Wainwright Adjusts Price Target on Legend Biotech to $86 From $87, Keeps Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.13% | 8.09B | |
+7.20% | 111B | |
+10.36% | 106B | |
-12.36% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-9.16% | 16.81B | |
+38.75% | 12.54B | |
+301.99% | 7.99B |
- Stock Market
- Equities
- LEGN Stock
- News Legend Biotech Corporation
- Morgan Stanley Raises Price Target on Legend Biotech to $85 From $65, Maintains Overweight Rating